Mathew Bijo, Oh Jong Min, Khames Ahmed, Abdelgawad Mohamed A, Rangarajan T M, Nath Lekshmi R, Agoni Clement, Soliman Mahmoud E S, Mathew Githa Elizabeth, Kim Hoon
Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India.
Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea.
Pharmaceuticals (Basel). 2021 Nov 11;14(11):1148. doi: 10.3390/ph14111148.
To develop new potent and highly selective MAO-B inhibitors from chalcone-thioethers, eleven chalcones-thioethers were synthesized and their monoamine oxidase (MAO) inhibition, kinetics, reversibility, and cytotoxicity of lead compounds were analyzed. Molecular dynamics were carried out to investigate the interactions. Compound showed potent inhibitory activity against MAO-B, with an IC value of 0.010 µM, followed by , , , and (IC = 0.017, 0.021, 0.023, and 0.026 µM, respectively). Interestingly, had an extremely high selectivity index (SI; 4860) for MAO-B. Reversibility and kinetic experiments showed that and were reversible and competitive inhibitors of MAO-B with K values of 0.0031 ± 0.0013 and 0.011± 0.001 µM, respectively. Both and were non-toxic to Vero cells with IC values of 241.8 and 116.3 µg/mL (i.e., 947.7 and 402.4 µM), respectively, and at these IC values, both significantly reduced reactive oxygen species (ROS) levels. and showed high blood-brain barrier permeabilities in the parallel artificial membrane permeability assay. Molecular dynamics studies were conducted to investigate interactions between and and the active site of MAO-B. Conclusively, and are potent and highly selective MAO-B inhibitors with little toxicity and good ROS scavenging abilities and it is suggested that both are attractive prospective candidates for the treatment of neurological disorders.
为了从查尔酮硫醚开发新型高效且高选择性的单胺氧化酶B(MAO-B)抑制剂,合成了11种查尔酮硫醚,并分析了它们对单胺氧化酶(MAO)的抑制作用、动力学、可逆性以及先导化合物的细胞毒性。进行了分子动力学研究以探究相互作用。化合物 对MAO-B表现出强效抑制活性,IC值为0.010 μM,其次是 、 、 和 (IC值分别为0.017、0.021、0.023和0.026 μM)。有趣的是, 对MAO-B具有极高的选择性指数(SI;4860)。可逆性和动力学实验表明, 和 是MAO-B的可逆性竞争性抑制剂,K值分别为0.0031±0.0013和0.011±0.001 μM。 和 对Vero细胞均无毒性,IC值分别为241.8和116.3 μg/mL(即947.7和402.4 μM),在这些IC值下,两者均显著降低了活性氧(ROS)水平。在平行人工膜通透性试验中, 和 显示出较高的血脑屏障通透性。进行了分子动力学研究以探究 和 与MAO-B活性位点之间的相互作用。总之, 和 是强效且高选择性的MAO-B抑制剂,毒性小,具有良好的ROS清除能力,表明两者都是治疗神经疾病有吸引力的潜在候选药物。